Dosimetry of a new P-32 ophthalmic applicator.

Purpose: The potential of P-32 ophthalmic applicator irradiation after pterygium excision has been demonstrated as an alternative to Sr∕Y-90 irradiation. This study aimed to provide the clinical dosimetry for this new applicator.

Methods: The prototype of a cylindrical P-32 applicator was fabricated according to the Monte Carlo (MC)-based design study.

One column operation for (90)Sr/(90)Y separation by using a functionalized-silica.

Organo-ceramic hybrid materials have been developed as the separation media for a (90)Sr/(90)Y generator system. Currently available (90)Y is generally extracted from a mother solution by a solvent extraction or a successive column operation. Both processes are successfully applied to produce (90)Y with a high quality standard.

Development of a high performance (188)W/(188)Re generator by using a synthetic alumina.

A synthetic alumina functionalized with a sulfate moiety has been developed as the column material of (99)Mo/(99m)Tc and (188)W/(188)Re generators. This material is synthesized by a sol-gel processing. In order to characterize the adsorbent for the (188)W/(188)Re separation, both batch and column contact experiments were conducted.

Potential use of P-32 ophthalmic applicator: Monte Carlo simulations for design and dosimetry.

Postoperative beta-irradiation after pterygium excision has been considered a valuable therapeutic procedure to reduce the recurrence rate. Recently, it was reported that beta-irradiation also substantially reduced the risk of surgical failure after glaucoma surgery. Pure beta-irradiation using a 90Sr/Y applicator has been almost exclusively used for this purpose.

Gene cloning, sequencing, and expression of an esterase from Acinetobacter lwoffii I6C-1.

The esterase-encoding gene, estA, was cloned from Acinetobacter lwoffii I6C-1 genomic DNA into Escherichia coli BL21(DE3) with plasmid vector pET-22b (pEM1). pEM1 has a 4.4-kb EcoRI insert that contained the complete estA gene.